Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2015) 37 EP195 | DOI: 10.1530/endoabs.37.EP195

1Serviço de Endocrinologia, Diabetes e Nutrição do Centro Hospitalar do Baixo Vouga, Aveiro, Portugal; 2Serviço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.


Introduction: Klinefelter syndrome (KS) is characterized by the presence of supernumerary X-chromosome and thus a 47,XXY karyotype. This syndrome remains underdiagnosed, with only about 25% of patients being identified, and only 10% during childhood.

Methods: Retrospective analysis of 11 KS patients followed-up in the Endocrinology Department of Coimbra’s Hospital and Universitary Center. The registered data included education and occupation, time and motif of diagnosis, co-morbidities and treatment. Patients were divided in two groups: A – diagnosis at pediatric age, n=8 and B – diagnosis during adulthood, n=3.

Results: The mean age of diagnosis was 34.45±14.2 years (A – 10.5±3.1 years and B – 42.7±14.2). Group A patients were diagnosed during workup of learning disabilities; on the last evaluation five had gynecomastia (62.5%) and two osteopenia (25%), none had carbohydrate metabolism disorder; they started testosterone replacement at the age of puberty; their final height was 170.3±9.8 cm; four group A patients completed highschool and one couldn’t read or write. One group B patient was diagnosed on account of infertility, and two on the workup of hypogonadotropic hypogonadism; on the last evaluation two had gynecomastia (66.7%), two osteopenia (66.7%), one osteoporosis (33.3%), two had psychiatric and behavioural disorders with cognitive impairment (66.7%), and two had diabetes mellitus with difficult metabolic control and proliferative retinopathy; their final height was 177.3±3.8 cm. One group B patient completed highschool and had an occupation; the other two didn’t finish junior high school and were unemployed.

Conclusion: Cognitive impairment was found in 90.9% of patients and was the most frequent comorbidity, with educational and professional impact. Ginecomastia and osteopenia were frequent as well. Timely diagnosis can result in a better care with proper follow-up and regular screening of possible comorbidities.

Article tools

My recent searches

No recent searches.

My recently viewed abstracts